Pi Therapeutics vs Rapport Therapeutics

Pi Therapeutics logo

Pi Therapeutics

Pioneering new therapies targeting the ubiquitin-proteasome system to combat cancer

est. 2015

VS
Rapport Therapeutics logo

Rapport Therapeutics

Precision medicines to match the complexity of the human brain

102 employees · est. 2022 · United States

Pi Therapeutics is the older company (2015 vs 2022).

Side-by-Side Comparison

Pi Therapeutics Rapport Therapeutics
Founded
2015 older 2022
Headquarters
Not tracked yet United States
Employees
Not tracked yet 102
Industry
Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Series B IPO
Total Funding
$19.70M $654.00M
Funding Rounds
1 4
Services
Not tracked yet Discovery of small molecule medicines, Development of CNS disorder treatments, Precision neuroscience research
Target Customers
Not tracked yet Patients with CNS disorders, Healthcare providers, Medical researchers
Taxonomy
Biopharmaceutical CompanyCancer TreatmentsDrug DiscoveryUbiquitin-proteasome SystemCancer TherapyTakeda Pharmaceuticals +9 Precision MedicineNeurological DisordersNeurocircuit TargetingReceptor-Associated ProteinsNeuromedicinesDrug Discovery +9
Website
pi-tx.com rapportrx.com
Pi Therapeutics logo

About Pi Therapeutics

Pi Therapeutics is a biopharmaceutical company dedicated to pioneering new therapies targeting the ubiquitin-proteasome system (UPS) to combat cancer. Since March 2015, the company has been operational within the FutuRx biotech accelerator located in Ness Ziona, Israel. The latest significant financ...

Rapport Therapeutics logo

About Rapport Therapeutics

Rapport Therapeutics, founded in 2022, is a pioneering company in the Biotechnology, Health Care, and Life Sciences industries. It is based in the United States, specifically in San Diego, CA and Boston, MA. The company is devoted to transforming neurological disorder treatments through precision me...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Pi Therapeutics and Rapport Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Pi Therapeutics or Rapport Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Pi Therapeutics was founded in 2015. Pi Therapeutics is a biopharmaceutical company dedicated to pioneering new therapies targeting the ubiquitin-proteasome system (UPS) to combat cancer. Since March 2015, the company has been operationa. Rapport Therapeutics was founded in 2022, based in United States, with 102 employees. Rapport Therapeutics, founded in 2022, is a pioneering company in the Biotechnology, Health Care, and Life Sciences industries. It is based in the United States, specifically in San Diego, CA and Bost.
Pi Therapeutics has raised $19.70M and Rapport Therapeutics $654.00M. Latest stage: Pi Therapeutics Series B, Rapport Therapeutics IPO.
Both work in Biotechnology and list drug discovery among their focus areas.

Compare Pi Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Pi Therapeutics on 12 Sep 2024, and Rapport Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes